U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07410052) titled 'Microbiome-Targeted Enhancement of Neurocognition With Probiotics-Riboflavin Combination' on Feb. 07.
Brief Summary: This randomized, double-blind, placebo-controlled trial will evaluate whether 12 weeks of supplementation with the probiotic Lactobacillus rhamnosus GG combined with colon-delivered riboflavin will improve cognitive performance and brain physiology in older adults with memory complaints. The study will assess changes in cognitive outcomes together with neurophysiological markers to explore potential gut-brain axis mechanisms. Through its rigorous design, the trial will aim to determine whether targeted modulation of t...